Endometrial Ablation Market Size to Worth Around USD 10.4 Bn by 2030

The global Endometrial Ablation market size is expected to reach USD 10.4 billion by 2030 and is expected to expand at a CAGR of 7.2% from 2021 to 2030.

Download Exclusive Sample of Report@ https://www.visionresearchreports.com/report/sample/38457

Growth Factors

Endometrial ablation is a highly efficient procedure that helps in removing or destroying the uterine endometrial lining in women who experience heavy menstrual bleeding using specific devices. The growing prevalence of gynecological disorders and growing public awareness about endometrial ablation are key contributing factors expected to propel the product demand. According to the International Federation of Gynecology and Obstetrics (FIGO), globally, the prevalence of Abnormal Uterine Bleeding (AUB) among reproductive-aged women is estimated to be between 3 to 30%

For women suffering from painful, heavy periods, endometrial ablation for endometriosis offers an alternative to chronic medication and hysterectomy treatments. Improved features and a higher demand for these procedures and devices due to the advantages over surgical methods, such as minimally invasive nature, low-risk profile, and easy operation, will support market growth.  

Report Highlights

The devices segment led the market in 2020 with a revenue share of more than 80%. Based on type, the market is segmented into devices and procedures. Endometrial ablation is a procedure for reducing severe menstrual bleeding by destroying the endometrium, a thin layer of tissue that lines the uterus. The number of women suffering from menorrhagia is on the rise, which is fueling the segment’s growth.

radiofrequency ablation dominated the devices segment with a revenue share of 36.3% and is further expected to continue its dominance during the forecast period. The growth is driven by the product’s convenience, speed of treatment, efficacy, and cost-efficiency compared to other ablation devices.

The hospital segment held the largest revenue share of over 65% in 2020. This is attributed to an increase in the number of patients being hospitalized for gynecological disorders, as hospitals provide excellent care as well as reimbursements. Also, hospitals possess advanced treatment devices, which contributes to the expansion of this segment.

The Ambulatory Surgery Center (ASC) is expected to exhibit the fastest growth rate during the forecast period, as a result of an increase in the number of ASCs. These healthcare settings offer more cost-effective services and a much more convenient environment, personalized treatment.

North America dominated the market and accounted for the largest revenue share of 43.6% in 2020. Rising cases of gynecological disorders, improvement in healthcare infrastructure, and a strong foundation of top industry players to deliver cutting-edge endometrial ablation devices are expected to drive market growth in the region.

Key Players

• Medtronic
• CooperSurgical Inc.
• Boston Scientific Corp.
• Ethicon, Inc. (Johnson & Johnson)
• Olympus Corp.
• Richard Wolf GmbH
• AngioDynamics
• Hologic, Inc.
• Minerva Surgical, Inc.

Report Coverage	Details
Market Size	US$ 10.4 billion by 2030
Growth Rate	CAGR of 7.2% From 2021 to 2030
Base Year	2020
Historic Data	2017 to 2020
Forecast Period	2021 to 2030
Segments Covered	Type, End-use
Regional Scope	North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Companies Mentioned	Medtronic; CooperSurgical Inc.; Boston Scientific Corp.; Ethicon, Inc. (Johnson & Johnson); Olympus Corp.; Richard Wolf GmbH; AngioDynamics; Hologic, Inc.; Minerva Surgical, Inc.

Market Segmentation

• Type
  • Devices
    • Cryoablation
    • Radiofrequency Ablation
    • Hydrothermal Ablation
    • Thermal Balloon
    • Microwave Energy
  • Procedures
• End-use
  • Hospitals
  • Clinics
  • Ambulatory Surgery Centers
• Regional
  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Norway
    • Sweden
    •  Russia
  • Asia Pacific
    • Japan
    • India
    • China
    • Australia
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
  • Middle East and Africa
    • Saudi Arabia
    • Turkey
    • UAE
    • Qatar
    • South Africa

Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38457

Reasons to Purchase this Report:

– Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
– Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
– Market value USD Million and volume Units Million data for each segment and sub-segment
– Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
– Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Table of Contents

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Endometrial Ablation Market, By Type

7.1.  Endometrial Ablation Market, by Type, 2021-2030

7.1.1.    Devices

7.1.1.1.        Market Revenue and Forecast (2017-2030)

7.1.2.    Procedures

7.1.2.1.        Market Revenue and Forecast (2017-2030)

Chapter 8.  Global Endometrial Ablation Market, By End-use

8.1.  Endometrial Ablation Market, by End-use, 2021-2030

8.1.1.    Hospitals

8.1.1.1.        Market Revenue and Forecast (2017-2030)

8.1.2.    Clinics

8.1.2.1.        Market Revenue and Forecast (2017-2030)

8.1.3.    Ambulatory Surgery Centers

8.1.3.1.        Market Revenue and Forecast (2017-2030)

Chapter 9.  Global Endometrial Ablation Market, Regional Estimates and Trend Forecast

9.1.  North America

9.1.1.    Market Revenue and Forecast, by Type (2017-2030)

9.1.2.    Market Revenue and Forecast, by End-use (2017-2030)

9.1.3.    U.S.

9.1.3.1.        Market Revenue and Forecast, by Type (2017-2030)

9.1.3.2.        Market Revenue and Forecast, by End-use (2017-2030)

9.1.4.    Rest of North America

9.1.4.1.        Market Revenue and Forecast, by Type (2017-2030)

9.1.4.2.        Market Revenue and Forecast, by End-use (2017-2030)

9.2.  Europe

9.2.1.    Market Revenue and Forecast, by Type (2017-2030)

9.2.2.    Market Revenue and Forecast, by End-use (2017-2030)

9.2.3.    UK

9.2.3.1.        Market Revenue and Forecast, by Type (2017-2030)

9.2.3.2.        Market Revenue and Forecast, by End-use (2017-2030)

9.2.4.    Germany

9.2.4.1.        Market Revenue and Forecast, by Type (2017-2030)

9.2.4.2.        Market Revenue and Forecast, by End-use (2017-2030)

9.2.5.    France

9.2.5.1.        Market Revenue and Forecast, by Type (2017-2030)

9.2.5.2.        Market Revenue and Forecast, by End-use (2017-2030)

9.2.6.    Rest of Europe

9.2.6.1.        Market Revenue and Forecast, by Type (2017-2030)

9.2.6.2.        Market Revenue and Forecast, by End-use (2017-2030)

9.3.  APAC

9.3.1.    Market Revenue and Forecast, by Type (2017-2030)

9.3.2.    Market Revenue and Forecast, by End-use (2017-2030)

9.3.3.    India

9.3.3.1.        Market Revenue and Forecast, by Type (2017-2030)

9.3.3.2.        Market Revenue and Forecast, by End-use (2017-2030)

9.3.4.    China

9.3.4.1.        Market Revenue and Forecast, by Type (2017-2030)

9.3.4.2.        Market Revenue and Forecast, by End-use (2017-2030)

9.3.5.    Japan

9.3.5.1.        Market Revenue and Forecast, by Type (2017-2030)

9.3.5.2.        Market Revenue and Forecast, by End-use (2017-2030)

9.3.6.    Rest of APAC

9.3.6.1.        Market Revenue and Forecast, by Type (2017-2030)

9.3.6.2.        Market Revenue and Forecast, by End-use (2017-2030)

9.4.  MEA

9.4.1.    Market Revenue and Forecast, by Type (2017-2030)

9.4.2.    Market Revenue and Forecast, by End-use (2017-2030)

9.4.3.    GCC

9.4.3.1.        Market Revenue and Forecast, by Type (2017-2030)

9.4.3.2.        Market Revenue and Forecast, by End-use (2017-2030)

9.4.4.    North Africa

9.4.4.1.        Market Revenue and Forecast, by Type (2017-2030)

9.4.4.2.        Market Revenue and Forecast, by End-use (2017-2030)

9.4.5.    South Africa

9.4.5.1.        Market Revenue and Forecast, by Type (2017-2030)

9.4.5.2.        Market Revenue and Forecast, by End-use (2017-2030)

9.4.6.    Rest of MEA

9.4.6.1.        Market Revenue and Forecast, by Type (2017-2030)

9.4.6.2.        Market Revenue and Forecast, by End-use (2017-2030)

9.5.  Latin America

9.5.1.    Market Revenue and Forecast, by Type (2017-2030)

9.5.2.    Market Revenue and Forecast, by End-use (2017-2030)

9.5.3.    Brazil

9.5.3.1.        Market Revenue and Forecast, by Type (2017-2030)

9.5.3.2.        Market Revenue and Forecast, by End-use (2017-2030)

9.5.4.    Rest of LATAM

9.5.4.1.        Market Revenue and Forecast, by Type (2017-2030)

9.5.4.2.        Market Revenue and Forecast, by End-use (2017-2030)

Chapter 10.  Company Profiles

10.1.              Medtronic

10.1.1.  Company Overview

10.1.2.  Product Offerings

10.1.3.  Financial Performance

10.1.4.  Recent Initiatives

10.2.              CooperSurgical Inc.

10.2.1.  Company Overview

10.2.2.  Product Offerings

10.2.3.  Financial Performance

10.2.4.  Recent Initiatives

10.3.              Boston Scientific Corp.

10.3.1.  Company Overview

10.3.2.  Product Offerings

10.3.3.  Financial Performance

10.3.4.  Recent Initiatives

10.4.              Ethicon, Inc. (Johnson & Johnson)

10.4.1.  Company Overview

10.4.2.  Product Offerings

10.4.3.  Financial Performance

10.4.4.  Recent Initiatives

10.5.              Olympus Corp.

10.5.1.  Company Overview

10.5.2.  Product Offerings

10.5.3.  Financial Performance

10.5.4.  Recent Initiatives

10.6.              Richard Wolf GmbH

10.6.1.  Company Overview

10.6.2.  Product Offerings

10.6.3.  Financial Performance

10.6.4.  Recent Initiatives

10.7.              AngioDynamics

10.7.1.  Company Overview

10.7.2.  Product Offerings

10.7.3.  Financial Performance

10.7.4.  Recent Initiatives

10.8.              Hologic, Inc.

10.8.1.  Company Overview

10.8.2.  Product Offerings

10.8.3.  Financial Performance

10.8.4.  Recent Initiatives

10.9.              Minerva Surgical, Inc.

10.9.1.  Company Overview

10.9.2.  Product Offerings

10.9.3.  Financial Performance

10.9.4.  Recent Initiatives

Chapter 11.  Research Methodology

11.1.              Primary Research

11.2.              Secondary Research

11.3.              Assumptions

Chapter 12.  Appendix

12.1.              About Us

Glossary of Terms

Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38457

Contact Us:

Vision Research Reports

Call: +1 9197 992 333

Email: sales@visionresearchreports.com